DOPAMINE-Î-HYDROXYLASE INHIBITORS
This invention relates to: (a) compounds of formula I (with R1 to R5 and A as defined herein) and pharmaceutically acceptable salts or solvates thereof that are useful as dopamine-β-hydroxylase inhibitors; (b) pharmaceutical compositions comprising such compounds, salts or solvates; (c) the use of...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
24.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to: (a) compounds of formula I (with R1 to R5 and A as defined herein) and pharmaceutically acceptable salts or solvates thereof that are useful as dopamine-β-hydroxylase inhibitors; (b) pharmaceutical compositions comprising such compounds, salts or solvates; (c) the use of such compounds, salts or solvates in therapy; (d) therapeutic methods of treatment using such compounds, salts or solvates; and (e) processes and intermediates useful for the synthesis of such compounds.
La presente se refiere a: (a) compuestos de la fórmula I (con R1 a R5 y A de acuerdo con lo definido en la presente memoria) y sales o solvatos aceptables para uso farmacéutico de los mismos que son útiles como inhibidores de dopamina-ß-hidroxilasa; (b) composiciones farmacéuticas que comprenden tales compuestos, sales o solvatos; (c) el uso de tales compuestos, sales o solvatos en una terapia; (d) métodos terapéuticos de tratamiento por el uso de tales compuestos, sales o solvatos; y (e) procesos e intermedios útiles para la síntesis de tales compuestos. (ver Fórmula). |
---|---|
Bibliography: | Application Number: MX2021014941 |